Gabriel Gambardella
Foot & Ankle Surgery · Bloomfield, CTNPI 1447577309
Payments from drug & device makers
Across 311 payments — averaging $318.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gramercy Extremity Orthopedics LLC$47K
- Smith+Nephew$20K
- Vilex LLC$12K
- Bioventus LLC$5K
- Celularity Inc.$5K
- Zimmer Biomet$3K
- plus $8K from 41 others
What the payments were for
- Royalty or licence$7,4408%
- Consulting fees$45,65846%
- Speaking & faculty fees$28,51629%
- Travel & lodging$4,1914%
- Food & beverage$11,39612%
- Education$1,7572%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Panta 2$13,458
- EVOS MINI$13,313
- ILIZAROV$13,313
- Taylor Spatial Frame$13,313
- SPATIAL FRAME$13,313
- Biovance$4,629
- Exogen$4,108
- Beta-BSM$3,000
- Distal Fibula Plating System$2,630
- HINTERMANN$2,200
- Cadence$2,097
- First Fuse 1st MTP Joint Plating System$2,000
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$1,651
- Integra XT$1,651
- FUZE$1,600
- First Fuse 1st MTP Joint Plating$1,250
- ACUMED$1,232
- INTEGRA$799
- Grafix$740
- Stravix$613
How this compares
$98,958 in reported general payments places this provider in the 95th percentile of 89 foot & ankle surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naftifine Hcl | 13 | $4,527 |
| Ketoconazole | 19 | $552 |
| Cephalexin | 14 | $507 |
| Doxycycline Monohydrate | 32 | $377 |
| Methylprednisolone | 31 | $261 |
| Ammonium Lactate | 11 | $216 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $186 |
| Silver Sulfadiazine | 14 | $103 |
| Gabapentin | 12 | $102 |
| Meloxicam | 20 | $19 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Bloomfield
- Allen FerrucciHamden$263K
- Thomas McDonaldEnfield$242K
- Jossie AbrahamNorwalk$152K
- James DejesusNaugatuck$65K
- Michael GazesWest Haven$51K
- Steven VyceWest Haven$50K
- David CaminearHamden$47K
- William ProbascoFairfield$26K
- Adebola AdelekeMiddletown$24K
- Rachel AlbrightDarien$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.